A Pan-TB Regimen Targeting Host and Microbe

NCT05686356 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

352

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Sutezolid
DRUG: N-acetyl cysteine
DRUG: Pretomanid
DRUG: Bedaquiline
COMBINATION_PRODUCT: Rifafour

Sponsor

The Aurum Institute NPC

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]